Cambridge Healthtech Institute

Join us on August 19 in Washington, D.C. at the Point-of-Care Histology Special Forum (part of the Next Generation Dx Summit) to explore many “better way” technologies that are working their way into laboratory practice. Richard Levenson, MD, FCAP, Professor in the department of pathology and laboratory medicine at the University of California, Davis will be co-chairing this afternoon conference with his colleague, Farzad Fereidouni, Ph.D. The pair helped develop one of the imaging systems that will be discussed and that could soon be commercially available. Diagnostics World’s Deborah Borfitz recently met with Dr. Levenson to discuss how the field is moving beyond slow and demanding conventional histopathology workflows to provide real-time, point-of-care tissue diagnostics. Visit https://lnkd.in/gb8R92Bz to read the complete article. To learn more about the special forum and register today to join us next month in Washington, D.C., visit https://lnkd.in/gu6ECT_U #NGDx

The countdown is on for the SCOPE Summit Europe in Barcelona! We’re thrilled to highlight these top companies making waves in the clinical research and development space: Aetion Inc: Shaping the future of scientific data insight and digital health. Alnylam Pharmaceuticals Inc: Pioneering groundbreaking clinical trial oversight. Boehringer Ingelheim Intl GmbH: Leading global clinical operations and analytics. IQVIA: Transforming trial management and site optimization technologies. Sanofi: Innovating in biostatistics and global clinical study units. Get ready for a summit full of networking, learning, and innovation! Join us in October! https://lnkd.in/ewWTsQhS #SCOPEEurope #HealthcareInnovation #ClinicalResearch #ClinicalDevelopment

In this month’s episode of Medtech Talk, host Geoff Pardo speaks with Everly Health's Dr. Liz Kwo MD, MBA, MPH about her new book Digital MD: Revolutionizing the Future of Healthcare, which provides an in-depth look at ROI development, how organizations think, sell, and build partnerships, and more. Dr. Kwo also shares her thoughts on the difference between efficacy and effectiveness, the changing role of the consumer (especially when considering data and AI), and what she expects in the next 20 years in the industry. Listen now: https://lnkd.in/eaHB4uk6

Now more than ever, the ability to not just connect, but interact, share insights, solve problems, build networks and collaborate with biopharma executives tackling the same challenges in strategic program, portfolio and resource management is crucial. Executive Decision Making for Pharma & Biotech is the premier event to explore the intersection of science, business, and operations with a close-knit community of like-minded biopharma executives. Taking place October 8-10, 2024, in Boston & virtually, this year's event offers a comprehensive platform for high-level discussions, interactive sessions, networking opportunities, breakout roundtables, and personalized 1:1 meetings. Register by July 26th to take advantage of our early savings deadline and join these two meeting to explore the intersection of science, business and operations. https://lnkd.in/e8C_kMeB #executivedeciosnmaking #portfioliomanagment #resourcemanagement

Registration Savings Available through this Friday, July 26   🚀 Join us at the Discovery on Target event in Boston, September 30 - October 3, 2024, to explore the latest in Innovative Drug Discovery Technologies! 🧬   Discover how technology and innovative drug discovery fuel each other in finding new drug targets and developing cutting-edge tools. Hear from top scientists in academia and industry about groundbreaking advancements.   🎤 Featured Talks: Covalent Strategies for Targeting the Kinome Speaker: Ken Hsu, PhD, The University of Texas at Austin Chemoproteomic Profiling in Multiple Cell Types Speaker: Doug Johnson, PhD, Biogen Analysis Platforms to Quantify Tumor-Immune Interactions Speaker: Arvind Rao, PhD, University of Michigan …and many more insightful sessions!   🔗 View full agenda and register now: https://lnkd.in/eBSMmYaQ #DrugDiscovery #Innovation #Biotech #Pharma #DiscoveryOnTarget #BostonDOT2024

Over 1,200 participants have reserved their spot for next month’s Bioprocessing Summit in Boston - See Who Is Attending! https://lnkd.in/eyk_xG-G Register today for the industry flagship event and your chance to: 🔹 Connect with 1,400+ global participants 🔹 Gain insights from world-renowned speakers 🔹 Network with cutting-edge tech & service providers 🔹 View research posters from future leaders Don't miss out on this incredible opportunity to drive innovation in #bioprocess R&D, scale-up, quality, and analytics! 📅 Save the date: August 19-22 📍 Boston, MA 👉 Learn More https://lnkd.in/gBHY_Rx #CHIBioprocessingSummit

Are you keeping up with the increasingly challenging and complex drug development landscape? Now more than ever it crucial to stay up to date with current frameworks, tools and technologies driving better analysis and decision making in pharmaceutical R&D portfolio management. CHI's annual Program & Portfolio Management conference assembles thought leaders who will present best practices to improve and optimize portfolio decision making. Join your peers to exchange ideas, acquire new strategies, benchmark your approach, and learn from industry leaders. Take advantage of our early savings deadline and register by this Friday to secure your spot and save $300. https://lnkd.in/e4fcJqRQ #portfoliomanagement #programmanagement #executivedecisionmaking

In the latest episode of The Chain, host Brandon DeKosky speaks with Harvard University’s Andrew Kruse about protein signaling and structural biology. Kruse explains what exactly bias signaling is and discusses the problems he and his team are working to resolve, as well as the findings in signaling receptors and biology that he’s most excited about, recent advancements that have caught his attention, and the new directions for him and his lab: https://lnkd.in/eJAvQfen

With our early registration deadline approaching July 26th, now is the perfect time to secure your spot at the 21st annual Strategic Resource Management conference that is part of the 2024 Executive Decision Making event for Pharm & Biotech. Gain valuable insights and lessons learned from our faculty of seasoned experts from Johnson & Johnson, AbbVie, Eli Lilly, Merck, Sanofi, Novartis, and elsewhere and hear invaluable insights into all aspects of resource management and forecasting, including:   ✅ Expanded Use of AI and Data Science in Resource Forecasting and Planning ✅ Linking Portfolio Intent to Resource Deployment: Best Practices to Enhance Operational Efficiency and Effectiveness ✅ Implementation of Resource/Capacity Management through Integration with Portfolio Management ✅ Opportunities to Drive Value: Implementing Fit-for-Purpose Resource Forecasting Capabilities in a Dynamic Environment ✅ Increasing Employee Efficiency Post-Portfolio Re-Prioritization and Company Transformation ✅ Optimizing Resource Allocation—Approaches for Internal, External, and Regional Sourcing https://lnkd.in/gUTt8EEc